CHRNA5-A3-B4 genetic variants alter nicotine intake and interact with tobacco use to influence body weight in Alaska Native tobacco users
Article first published online: 5 JUL 2013
© 2013 Society for the Study of Addiction
Volume 108, Issue 10, pages 1818–1828, October 2013
How to Cite
Zhu, A. Z. X., Renner, C. C., Hatsukami, D. K., Benowitz, N. L. and Tyndale, R. F. (2013), CHRNA5-A3-B4 genetic variants alter nicotine intake and interact with tobacco use to influence body weight in Alaska Native tobacco users. Addiction, 108: 1818–1828. doi: 10.1111/add.12250
- Issue published online: 13 SEP 2013
- Article first published online: 5 JUL 2013
- Accepted manuscript online: 21 MAY 2013 06:20AM EST
- Manuscript Accepted: 10 MAY 2013
- Manuscript Revised: 1 APR 2013
- Manuscript Received: 30 JAN 2013
- National Cancer Institute. Grant Numbers: HHSN261200700462P, CA114609
- National Institute on Drug Abuse. Grant Number: DA012353
- National Institutes of Health. Grant Numbers: DA020830, DA012353
- Endowed Chair in Addiction for the Department of Psychiatry (RFT), Canadian Institutes of Health Research. Grant Numbers: MOP86471, TMH109787
- Ontario Graduate Scholarship
- CAMH and the CAMH foundation
- Canada Foundation for Innovation. Grant Numbers: 20289, 16014
- Ontario Ministry of Research and Innovation
- Alaska Native people;
Background and aims
Gene variants in CHRNA5-A3-B4, which encode for the α5, α3 and β4 nicotinic receptor subunits, are associated with altered smoking behaviors in European Americans. Little is known about CHRNA5-A3-B4 and its association with smoking behaviors and weight in Alaska Native people, which is a population with high prevalence but low levels of tobacco consumption, extensive smokeless tobacco use and high rates of obesity. We investigated CHRNA5-A3-B4 haplotype structure and its association with nicotine intake and obesity in Alaska Native people.
Design, setting and participants
A cross-sectional study of 400 Alaska Native individuals, including 290 tobacco users.
CHRNA5-A3-B4 genotype, body weight and tobacco consumption biomarkers such as plasma cotinine and urinary total nicotine equivalents (TNE).
Alaska Native people have a distinct CHRNA5-A3-B4 haplotype structure compared with European/African Americans. In 290 Alaska Native tobacco users the ‘G’ allele of rs578776, which tagged a 30kb haplotype in CHRNA5-A3-B4, was prevalent (16%) and associated significantly with nicotine intake (20% higher plasma cotinine, P < 0.001, 16% higher TNE, P = 0.076), while rs16969968 was not associated with nicotine intake. Rs578776 acted in combination with CYP2A6, the main nicotine-metabolizing enzyme, to increase nicotine intake by 1.8-fold compared with the low-risk group (P < 0.001). Furthermore, rs2869950, a single nucleotide polymorphism 5′ to CHRNB4, was associated significantly with increased body mass index (P < 0.01) in the tobacco users even after controlling for differences in nicotine intake (P < 0.01).
Genetic variants in CHRNA5-A3-B4 alter nicotine intake and body mass index in a population of Alaska Native people, who have a distinct haplotype structure, smoking behaviors and prevalence of obesity.